✦ LIBER ✦

Recommendations and best practice for the current state of the art in turbulence modelling

✍ Scribed by Batten, Paul; Goldberg, Uri; Peroomian, Oshin; Chakravarthy, Sukumar

Book ID: 118253116
Publisher: Taylor and Francis Group
Year: 2009
Tongue: English
Weight: 268 KB
Volume: 23
Category: Article
ISSN: 1061-8562
DOI: 10.1080/10618560902832720

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposable bioreactors: the current stat

Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology

✍ Regine Eibl; Stephan Kaiser; Renate Lombriser; Dieter Eibl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 251 KB

Personalized task recommendation in crow

Personalized task recommendation in crowdsourcing information systems — Current state of the art

✍ Geiger, David (author);Schader, Martin (author) 📂 Article 📅 2014 🏛 Elsevier B.V. 🌐 English ⚖ 417 KB

Personalized task recommendation in crow

Personalized task recommendation in crowdsourcing information systems — Current state of the art

✍ Geiger, David (author);Schader, Martin (author) 📂 Article 📅 2014 🏛 Elsevier B.V. 🌐 English ⚖ 417 KB

Effects of diabetes on the vascular syst

Effects of diabetes on the vascular system: current research evidence and best practice recommendations

✍ Phyllis A Gordon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Effects of diabetes on the vascular syst

Effects of diabetes on the vascular system: current research evidence and best practice recommendations

✍ Buchanan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 28 KB

State of the art in restless legs syndro

State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome

✍ Wolfgang H. Oertel; Claudia Trenkwalder; Marco Zucconi; Heike Benes; Diego Garci 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Dopaminergic agents are the best-studied agents and are considered first-line treatment of restless legs syndrome (RLS). Extensive data are available for levodopa, pramipexole, and ropinirole, which have approval for the indication RLS, and to a smaller extent for cabergoline, pergolide, and rotigot